Abstract
Background Historical data suggest 15% of laboratory animal workers develop IgE sensitisation and 10% symptoms of laboratory animal allergy (LAA), including occupational asthma. Individually ventilated cages (IVCs) are replacing conventional open cages; we sought to evaluate their impact on the development of LAA.
Methods We surveyed 750 laboratory animal workers and measured airborne Mus m 1 (mouse allergen) levels in seven UK institutions. We compared the prevalence of sensitisation to mouse proteins (by specific IgE assay or skin prick test) and of work-related allergic symptoms in IVC-only and open cage units.
Results Full-shift Mus m 1 levels were lower in IVC than open cage units (geometric mean 1.00 (95% CI 0.73–1.36) versus 8.35 (95% CI 6.97–9.95) ng·m−3; p<0.001), but varied eight-fold across the IVC units (geometric mean range 0.33–4.12 ng·m−3). Primary analyses on data from 216 participants with ≤3 years exposure to mice revealed a lower prevalence of sensitisation in those working in IVC units compared with conventional cage units (2.4% (n=2) versus 9.8% (n=13); p=0.052). Sensitisation in IVC units varied from 0% to 12.5%; the use of fitted respiratory protection was less common in IVC units where prevalence of sensitisation was higher. Work-related allergy symptoms were more frequently reported by mouse-sensitised individuals (46.7% versus 10.9%; p<0.001) and only by those working in open cage units.
Conclusion In contemporary practice, LAA is now largely preventable with the use of IVC systems and the judicious use of appropriate respiratory protection.
Abstract
Laboratory animal allergy, an important form of occupational asthma, can be prevented in modern research units using a multifaceted approach including individually ventilated cages to contain aeroallergen exposure and careful use of respiratory protection http://ow.ly/r6dM30oj3Ij
Footnotes
This article has supplementary material available from erj.ersjournals.com
Conflict of interest: S.J. Schofield has nothing to disclose.
Conflict of interest: J. Canizales has nothing to disclose.
Conflict of interest: B. Fitzgerald has nothing to disclose.
Conflict of interest: J. Potts has nothing to disclose.
Conflict of interest: M. Jones has nothing to disclose.
Conflict of interest: P. Cullinan has nothing to disclose.
Conflict of interest: J.R. Feary has nothing to disclose.
Support statement: This work was funded by the National Institute for Health Research. Funding information for this article has been deposited with the Crossref Funder Registry.
- Received January 24, 2019.
- Accepted March 23, 2019.
- Copyright ©ERS 2019